Showing results (71-80 of 137) with videos related to

Sort By:
Pageof 14
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|February 3, 2022
The similar eye movement dysfunction between major depressive disorder, bipolar depression and bipolar maniaYing Wang, Hai-Long Lyu, Xiao-Han Tian, et al.
Trials|February 24, 2021
Dietary fiber and probiotics for the treatment of atypical antipsychotic-induced metabolic side effects: study protocol for a randomized, double-blind, placebo-controlled trialChenchen Liu, Dongyu Kang, Jingmei Xiao, et al.
Frontiers in Pharmacology|April 3, 2025
Akkermansia muciniphila ameliorates olanzapine-induced metabolic dysfunction-associated steatotic liver disease via PGRMC1/SIRT1/FOXO1 signaling pathwayHui Chen, Ting Cao, ChenQuan Lin, et al.
Biological Psychiatry|July 13, 2025
Effects of Accelerated Intermittent Theta-Burst Stimulation Targeting the Superior Frontal Gyrus on Cognitive Function in Patients with Schizophrenia: A Double-Blind, Randomized, Sham-Controlled Clinical TrialXingjie Peng, Chuhan Song, Yuhan Su, et al.
Schizophrenia Research|July 6, 2016
Relationship between long-term use of a typical antipsychotic medication by Chinese schizophrenia patients and the bone turnover markers serum osteocalcin and β-CrossLapsBeibei Zhang, Lu Deng, Haishan Wu, et al.
Frontiers in Psychology|September 27, 2021
Sex Differences in Psychological Status and Fatigue of Frontline Staff After the COVID-19 Outbreak in China: A Cross-Sectional StudyZiwei Teng, Yuhan Su, Jindong Chen, et al.
Lipids in Health and Disease|July 25, 2024
Orlistat for the treatment of antipsychotic-induced weight gain: an eight-week multicenter, randomized, placebo-controlled, double-blind trialPeng Xie, Tiannan Shao, Yujun Long, et al.
Schizophrenia Bulletin Open|August 15, 2024
Eye Movement Abnormalities Can Distinguish First-Episode Schizophrenia, Chronic Schizophrenia, and Prodromal Patients From Healthy ControlsHailong Lyu, David St Clair, Renrong Wu, et al.
Schizophrenia (Heidelberg, Germany)|May 17, 2024
Combination of UGT1A1 polymorphism and baseline plasma bilirubin levels in predicting the risk of antipsychotic-induced dyslipidemia in schizophrenia patientsChenquan Lin, Shuangyang Zhang, Ping Yang, et al.
Scientific Reports|May 19, 2016
Patients with first-episode, drug-naive schizophrenia and subjects at ultra-high risk of psychosis shared increased cerebellar-default mode network connectivity at restHouliang Wang, Wenbin Guo, Feng Liu, et al.
Pageof 14